Clinical Director, Movement Disorders Division, Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-3232, USA.
Parkinsonism Relat Disord. 2011 Feb;17(2):77-83. doi: 10.1016/j.parkreldis.2010.08.022. Epub 2010 Sep 20.
Both pathologic and clinical studies of autonomic pathways have expanded the concept of Parkinson disease (PD) from a movement disorder to a multi-level widespread neurodegenerative process with non-motor features spanning several organ systems. This review integrates neuropathologic findings and autonomic physiology in PD as it relates to end organ autonomic function. Symptoms, pathology and physiology of the cardiovascular, skin/sweat gland, urinary, gastrointestinal, pupillary and neuroendocrine systems can be probed by autopsy, biopsy and non-invasive electrophysiological techniques in vivo which assess autonomic anatomy and function. There is mounting evidence that PD affects a chain of neurons in autonomic pathways. Consequently, autonomic physiology may serve as a window into non-motor PD progression and allow the development of mechanistically based treatment strategies for several non-motor features of PD. End-organ physiologic markers may be used to inform a model of PD pathophysiology and non-motor progression.
自主神经通路的病理和临床研究拓宽了帕金森病 (PD) 的概念,将其从运动障碍转变为多水平广泛的神经退行性过程,伴有跨越多个器官系统的非运动特征。本文综述了 PD 中与终末器官自主功能相关的神经病理学发现和自主生理学。心血管、皮肤/汗腺、泌尿、胃肠、瞳孔和神经内分泌系统的症状、病理和生理学可通过尸检、活检和活体非侵入性电生理学技术进行研究,这些技术可评估自主神经解剖和功能。越来越多的证据表明,PD 影响自主神经通路中的一连串神经元。因此,自主生理学可能成为非运动性 PD 进展的窗口,并为 PD 的几种非运动特征开发基于机制的治疗策略。终末器官生理标志物可用于告知 PD 病理生理学和非运动进展的模型。